Peer-reviewedCC BY-NC-NDJournal of thoracic disease18 Aug 2026

Symptoms improvement and lung function benefits of fixed triple therapy with beclomethasone/formoterol/glycopyrronium inhalation powder in patients with moderate-to-severe COPD: outcomes of the Bulgarian arm of the RESPONSE study

Rosen E. Petkov¹
Andrey N. Kenderov²
Neli L. Rodopska²
Evgeni V. Mekov¹
Krassimir Kalinov³

¹Department of Pulmonary Diseases , Medical University-Sofia , Sofia , ;
²Chiesi Bulgaria Ltd ., Sofia , ;
³Independent Consultant in Biostatistics , Sofia ,

Particle Morphometrics of Glycopyrronium-Formoterol-Budesonide Inhalation Blends Influence Pulmonary Deposition and Bronchodilator Response in Chronic Obstructive Pulmonary Disease (COPD): A Gamma Scintigraphy Study
Gaurav K Jain, Abha Mishra, Nilesh Chandra +1
Cureus26 Sep 2026Peer-reviewedCC BY 4.0Full textGeneral medicinePMCEurope PMC
Real-World Effectiveness of Budesonide/Glycopyrronium/Formoterol (BGF) Fixed-Dose Combination in Patients with COPD (RECORD Study): A Prospective Observational Study
Henrik Watz, Michael Watt, Tamsin Morris +5
International Journal of Chronic Obstructive Pulmonary Disease30 Oct 2026Peer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
Real-World Renal Effects of Dapagliflozin in Bulgarian Patients with Chronic Kidney Disease of Predominantly Glomerular Origin: A Two-Year Comparative Cohort Study with Historical Controls
Veronica Aladzhova, Teodora Ilieva, Bilyana Vasileva +8
Biomedicines1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Nutrient profiling of foods on the Bulgarian market
VL Duleva, EN Chikova-Iscener
The European Journal of Public Health1 Oct 2026Peer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthPMCEurope PMC
OP–008 Effect of virtual reality and distraction cards during inhalation therapy
Tuğba Karakuş Türker, Tuğba Karakaya
BMJ Paediatrics Open1 Oct 2026Peer-reviewedCC BYObstetrics, gynaecology & paediatricsDOAJ

Cite

BibTeX

@article{petkov2026symptoms,
  title = {{Symptoms improvement and lung function benefits of fixed triple therapy with beclomethasone/formoterol/glycopyrronium inhalation powder in patients with moderate-to-severe COPD: outcomes of the Bulgarian arm of the RESPONSE study}},
  author = {Rosen E. Petkov and Andrey N. Kenderov and Neli L. Rodopska and Evgeni V. Mekov and Krassimir Kalinov},
  journal = {Journal of thoracic disease},
  year = {2026},
  month = aug,
  url = {https://europepmc.org/article/PMC/PMC13655834},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Symptoms improvement and lung function benefits of fixed triple therapy with beclomethasone/formoterol/glycopyrronium inhalation powder in patients with moderate-to-severe COPD: outcomes of the Bulgarian arm of the RESPONSE study
AU  - Rosen E. Petkov
AU  - Andrey N. Kenderov
AU  - Neli L. Rodopska
AU  - Evgeni V. Mekov
AU  - Krassimir Kalinov
PY  - 2026
DA  - 2026/08/18
JO  - Journal of thoracic disease
UR  - https://europepmc.org/article/PMC/PMC13655834
SN  - 2072-1439
SN  - 2077-6624
ER  -

Related

Cite